NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.

To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

• Research Experiences

• Courses for Skills Development

• Mentoring Activities

• Curriculum or Methods Development

The purpose of the Research and Entrepreneurial Development Immersion (REDI): NIA Entrepreneurship Enhancement Award (R25) is to promote the development of entrepreneurial education programs that are designed to broaden the skillset of graduate students and postdocs, as well as early career master's, Ph.D., and Dr.P.H. scientists, in fields relevant to the mission of NIA, including aging and Alzheimer's disease (AD) research. The goal of this program is to prepare trainees for a wide range of career paths, including those that are outside the normal research environment.

View funding announcement

Alzheimer's Association Special RFA: Advancing Research on Care and Outcome Measures

The Advancing Research on Care & Outcome Measurement (ARCOM) program aims to address significant gaps in care and outcome measurement and provide an opportunity to advance research so that care providers can ensure they are implementing evidence-based practices and achieving desired outcomes. Work funded through ARCOM must directly advance research projects focused on development of new (and/or validations of previously developed) measures of care and evaluate the use of such measures in improving care and outcomes across diverse and underrepresented populations at different stages of dementia.

The Alzheimer's Association anticipates awarding up to 8 ARCOM grants with a maximum funding of USD $250,000 each over a period of one to two years. For more information about the program, funding, and eligibility, see the ARCOM RFA and webpage.

Learn more

Requesting Applications for Career Development Awards

The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer's Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory is now accepting applications for the Career Development Award (CDA). These CDAs support the development of MD, PhD, or equivalent researchers who seek careers conducting embedded pragmatic clinical trials (ePCTs) for people living with AD/ADRD and their care partners.

The IMPACT Collaboratory will fund up to two 2-year CDAs, prioritizing applications that address dementia care for people of all backgrounds and promote health equity. Each award will provide up to $220,000 in direct costs over two years with an indirect cost rate capped at 8%. Awardees are required to devote a minimum of 75% effort toward the goals of the award. Eligible applicants include MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their care partners. Applicants are typically within 7 years of their post-doctoral training program at the time of application. Exceptions will be made in this round of funding for investigators with more than 7 years who can demonstrate evidence of changing their career path to pursue research on ePCTs among PLWD. Such applicants must request prior approval. Applications are due Thursday, September 15, 2022 by 5pm ET. An informational webinar will be hosted on Wednesday, June 29, 2022 at 2:00 PM ET to provide investigators with an overview of application details. Investigators will have the opportunity to ask questions. Use this link for required pre-registration.